Pyridam Farma Tbk PT
IDX:PYFA
Pyridam Farma Tbk PT
Other Receivables
Pyridam Farma Tbk PT
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Other Receivables
Rp15.1B
|
CAGR 3-Years
32%
|
CAGR 5-Years
129%
|
CAGR 10-Years
48%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Other Receivables
Rp193.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Other Receivables
Rp216.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Other Receivables
Rp50.4B
|
CAGR 3-Years
52%
|
CAGR 5-Years
32%
|
CAGR 10-Years
16%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Other Receivables
Rp294.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Other Receivables
Rp154.2B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
32%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Other Receivables?
Other Receivables
15.1B
IDR
Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Other Receivables amounts to 15.1B IDR.
What is Pyridam Farma Tbk PT's Other Receivables growth rate?
Other Receivables CAGR 10Y
48%
Over the last year, the Other Receivables growth was 432%. The average annual Other Receivables growth rates for Pyridam Farma Tbk PT have been 32% over the past three years , 129% over the past five years , and 48% over the past ten years .
